The experience of hydroxychloroquine in managing RA patients with diabetes mellitus suggested the anti-diabetic potential of the drug. The anti-diabetic effect has been effectively proven by clinical trials and the drug has been recently approved for managing diabetes. Emerging studies suggest its clinical use in obstetrical  ntiphospholipid syndrome (APS) and other recurrent
pregnancy loss, especially in refractory cases. Several studies are being conducted to determine whether hydroxychloroquine should be recommended as a part of APS treatment. The immune modulation potential
of the drug has also been investigated for the  anagement of cancer.

Hydroxychloroquine in Diabetes Q & A

In this book, the author has attempted to discuss the problems related with Recurrent Pregnancy Loss and the treatment for various causes in the form of  question and answers.  Also, the author has adequately addressed the controversial areas with suitable literature evidence. 

Hydroxychloroquine in Diabetes Q & A

₹ 200.00

Recurrent Pregnancy Loss - Causes and Treatment

₹ 400.00

Topiroxostat - Cover page

₹ 100.00

Tofacitinib In Ulcerative Colitis - Q & A

₹ 200.00

Copyright © 2022-23 ChanRe Bookshop . All rights reserved.